HIGHLIGHTS
- who: Erica M. Pasini from the (1-u03b2) to detect a statistically significant difference in treatment effect (development of parasitemia in control versus total protection in the treatment group) and a type I error of , (u03b1). As relapses cannot be detected under continuous chloroquine coverage and we want to additionally assess the role of blood stages in this model, a further four animals were included for this purpose. This allows making the best use of the additional animals as we both monitor the relapses, which is needed to assess timelines of the vaccination protocol and the role . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.